| |
| |
|
| Insider
Information: |
Lamattina John L |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
512,782 |
|
|
Indirect Shares
|
59,053 |
|
|
| Direct
Value |
$15,491,685 |
|
|
|
Indirect Value
|
$1,639,902 |
|
|
| Total
Shares |
571,835 |
|
|
| Total
Value |
$17,131,587 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -56.8%
|
-36.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pfizer Inc |
PFE |
Senior Vice President |
2007-06-29 |
383,190 |
2007-06-29 |
59,053 |
Premium* |
|
|
Thermo Fisher Scientific |
TMO |
Director |
2004-03-09 |
3,000 |
2004-03-09 |
0 |
Premium* |
|
|
Human Genome Sciences Inc |
HGSI |
Director |
2012-07-30 |
0 |
2008-11-12 |
0 |
Premium* |
|
|
Ligand Pharmaceuticals Inc |
LGND |
Director |
2023-06-09 |
28,263 |
2011-02-07 |
0 |
Premium* |
|
|
Larimar Therapeutics Inc |
LRMR |
Director |
2019-01-24 |
31,376 |
2017-02-13 |
0 |
Premium* |
|
|
Immunome Inc. |
IMNM |
Director |
2023-01-15 |
66,953 |
2020-10-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
73 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2004-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
17,910 |
299,121 |
|
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2004-03-25 |
4 |
A |
$0.00 |
$0 |
D/D |
29,850 |
324,257 |
|
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2005-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
61,440 |
389,032 |
|
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2006-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
85,440 |
415,200 |
|
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2007-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
73,770 |
495,132 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,666 |
1,666 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2011-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
32,500 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,148 |
16,814 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2012-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
47,009 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2012-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
4,721 |
21,535 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2013-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,621 |
25,156 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2014-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,484 |
22,840 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2015-04-24 |
4 |
A |
$0.00 |
$0 |
D/D |
925 |
20,980 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2016-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
810 |
20,290 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Director |
– • – |
2017-02-13 |
4 |
A |
$4.18 |
$47,497 |
D/D |
11,363 |
11,363 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2017-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
666 |
20,956 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Director |
– • – |
2018-01-03 |
4 |
A |
$5.18 |
$47,495 |
D/D |
9,169 |
20,532 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2018-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
493 |
21,449 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Director |
– • – |
2019-01-24 |
4 |
A |
$4.38 |
$47,497 |
D/D |
10,844 |
31,376 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2019-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
835 |
22,284 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2020-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
831 |
24,768 |
0 |
- |
|
| IMNM |
Immunome Inc. |
Director |
– • – |
2020-10-06 |
4 |
A |
$0.00 |
$0 |
D/D |
46,388 |
46,388 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2021-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
630 |
25,398 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2022-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,004 |
26,402 |
0 |
- |
|
| IMNM |
Immunome Inc. |
Director |
– • – |
2023-01-15 |
4 |
A |
$4.00 |
$60,500 |
D/D |
15,125 |
66,953 |
0 |
- |
|
73 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
